Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| AGENUS (NASDAQ: AGEN) | Delayed: 6.56 -0.28 (4.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.84 | 52 Week High | $7.49 | |||
| Open | $6.85 | 52 Week Low | $2.61 | |||
| Day High | $6.86 | P/E | N/A | |||
| Day Low | $6.43 | EPS | $-1.10 | |||
| Volume | 285,812 | |||||
